Nucleus Genomics is a New York-based consumer genomics company that sells a $399 at-home, clinical-grade whole-genome sequencing kit and a software platform that turns a person's full DNA sequence into readable reports on disease risk, carrier status, traits, and longevity. Founded in 2021 by Thiel Fellow Kian Sadeghi, Nucleus pairs whole-genome data with polygenic risk scores and lifestyle inputs to estimate risk for common, complex conditions. In 2025 it expanded into reproductive products - carrier screening, partner DNA alignment, and a controversial embryo-ranking tool, Nucleus Embryo - that put the company at the center of a public debate over the science and ethics of genetic selection.
Andrew Lacy is the Founder and CEO of Prenuvo, the company making proactive whole-body MRI scanning a mainstream healthcare tool. A Melbourne-born, Stanford-trained entrepreneur, he previously co-founded Tapulous - the mobile gaming company behind Tap Tap Revenge, acquired by Disney in 2010 - before pivoting to healthcare. At Prenuvo, he has raised $177M in total funding (including a $120M Series B in 2024), grown the company to 110,000+ members across 17 North American clinics, and secured FDA clearance for AI-powered body composition analysis, with plans to expand into Europe and Australia.
Prenuvo runs a chain of clinics built around a 60-minute whole-body MRI designed to spot cancer, aneurysms and hundreds of other conditions before symptoms show up. Founded by Andrew Lacy and radiologist Raj Attariwala, the company is trying to drag American healthcare from reactive to preventive, one scan at a time.
Barton Wells is the co-founder, CEO, and CTO of DexaFit Dx, a Palo Alto-based health technology company using AI and full-body DXA scans to detect coronary artery disease, Type 2 diabetes, and other chronic conditions early and non-invasively. A Stanford-trained mathematician and former world-ranked open water marathon swimmer, Wells brings 30+ years of AI, computer vision, and iOS engineering experience - spanning stints at Dropbox and multiple startups - to the challenge of transforming a 7-minute medical scan into a multi-disease risk screening platform for insurers, employers, and individuals.
Miray Tayfun is the co-founder and CEO of Vivoo, a San Francisco-based health technology company that turns urine test strips into personalized wellness insights via a mobile app. A bioengineering graduate and serial founder, she built Vivoo from a personal frustration with expensive and slow health testing into a platform serving 300,000+ users across 50+ countries. Backed by Tim Draper and $19.4M in total funding, Vivoo expanded from subscription test strips to a $99 smart toilet unveiled at CES 2026, named Best of CES by Gadget Flow. Tayfun is a 2019 Australian Financial Review Top 100 Women of Influence honoree and 2018 Laureate Here for Good Award winner.